Epstein barr virus associated Hodgkin and non-Hodgkin lymphoma

Liqaa Hadi Naser; ‏‪Kifah Fadhil Hassoon‬‬‬‬‏‬‬‬‬‬‬‬‬‬‬

doi:10.53730/ijhs.v6nS4.11783

Authors

Liqaa Hadi Naser
hadylqa7@gmail.com
Faculty of Medicine, University of Kufa, Iraq
‏‪Kifah Fadhil Hassoon‬‬‬‬‏‬‬‬‬‬‬‬‬‬‬ Faculty of Veterinary Medicine, University of Kufa, Iraq

Keywords:

EBV, FFPET, IHC, HL, Hodgkin disease

Abstract

Background: The Epstein-Barr virus (EBV) has been linked to a variety of B-cell lymphomas, including Burkitt lymphoma (BL), classical Hodgkin lymphoma (cHL), and diffuse large B-cell lymphoma (DLBCL), at rates ranging from 5 to 10% of DLBCL cases to >95% in endemic BL. Methods: The Present study conducted in AL-Najaf Holy City; it is a cross sectional study. All patients were recruited from Middle Euphrates Cancer Research Unit Laboratory, from pre-existing samples. Tissues collected from the previously mentioned laboratory were fixed in 10% formalin and placed in a cassette before being embedded in paraffine. The tissues were examined and diagnosed as with Hodgkin disease. Eighty samples were subjected in the present study. All study group was diagnosed formerly as paraffin imbedding blocks. Molecular analysis also used to detection of EBV-LMP-1 Gene. Histopathological examination using hematoxylin and eosine stain (H&E) then examining under light microscope to check for EBV-LMP-1 protein in twenty block samples of tissues with lymphoma. Results: The result of the current study revealed that EBV-LMP-1 marker found in 12.5% of cases that had been diagnosed by PCR and IHC.

Downloads

Download data is not yet available.

References

Abdulla,NY, Aljanaby, IAJ, Hasan, TH , Aljanaby, AAJ. 2022. Assessment of ß-lactams and Carbapenems Antimicrobials Resistance in Klebsiella Oxytoca Isolated from Patients with Urinary Tract Infections in Najaf, Iraq. Archives of Razi Institute, Vol. 77, No. 2 (2022) 669-673

Alhasnawi HMR, Aljanaby AAJ. Evaluation of Galectin-3 and CD19 in Helicobacter pylori patients infected with stomach cancer. Gene Reports 26 (2022) 101520. https://doi.org/10.1016/j.genrep.2022.101520.

Aljanaby, A.A.J., Al-Faham, Q.M.H., Aljanaby, I.A.J. and Hasan, T.H., 2022. Immunological role of cluster of differentiation 56 and cluster of differentiation 19 in patients infected with mycobacterium tuberculosis in Iraq. Gene Reports, p.101514. doi.org/10.1016/j.genrep.2022.101514

Castillo, Jorge J. et al. 2018. “EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified: 2018 Update on Diagnosis, Risk-Stratification and Management.” American Journal of Hematology 93(7): 953–62. https://onlinelibrary.wiley.com/doi/10.1002/ajh.25112.

de Martel, Catherine et al. 2020. “Global Burden of Cancer Attributable to Infections in 2018: A Worldwide Incidence Analysis.” The Lancet Global Health 8(2): e180–90. http://dx.doi.org/10.1016/S2214-109X(19)30488-7.

Ding, Yiyang et al. 2021. “Epstein–Barr Virus and Cytomegalovirus Reactivation after Allogeneic Hematopoietic Cell Transplantation in Patients with Non–Hodgkin Lymphoma: The Prevalence and Impacts on Outcomes.” Annals of Hematology 100(11): 2773–85. http://dx.doi.org/10.1038/s41379-020-0575-3.

Epstein, M. A., and Y. M. Barr. 1964. “Cultivation in Vitro of Human Lymphoblasts From Burkitt’S Malignant Lymphoma.” The Lancet 283(7327): 252–53.

Fattakhov, N., Normatova, S., Madaminov, S., Tilyakhodzhaeva, G., & Abdulkhakimov, A. (2021). Hirudotherapy as an effective method for treatment of migraine - a disease of unknown etiology. International Journal of Health & Medical Sciences, 4(2), 232-237. https://doi.org/10.31295/ijhms.v4n2.1714

Ferlay, Jacques et al. 2021. “Cancer Statistics for the Year 2020: An Overview.” International Journal of Cancer 149(4): 778–89.

Grewal, Ravnit et al. 2018. “Hodgkin’s Lymphoma and Its Association with EBV and HIV Infection.” Critical Reviews in Clinical Laboratory Sciences 55(2): 102–14. https://doi.org/10.1080/10408363.2017.1422692.

Hadi, H. I., & Aljanaby, A. A. J. (2022). Correlation between CD14 and CD163 in duodenal ulcer and gastric cancer patients infected with Helicobacter Pylori. International Journal of Health Sciences, 6(S1), 4211–4217. https://doi.org/10.53730/ijhs.v6nS1.5593

Horesh, Nurit, and Netanel A. Horowitz. 2014. “Does Gender Matter in Non-Hodgkin Lymphoma? Differences in Epidemiology, Clinical Behavior, and Therapy.” Rambam Maimonides Medical Journal 5(4): e0038.

Houldcroft, Charlotte J., and Paul Kellam. 2015. “Host Genetics of Epstein-Barr Virus Infection, Latency and Disease.” Reviews in Medical Virology 25(2): 71–84. https://onlinelibrary.wiley.com/doi/10.1002/rmv.1816.

Huang, Junjie et al. 2022. “Incidence, Mortality, Risk Factors, and Trends for Hodgkin Lymphoma: A Global Data Analysis.” Journal of Hematology & Oncology 15(1): 57. https://doi.org/10.1186/s13045-022-01281-9.

Jimenez, O. et al. 2021. “Epstein–Barr Virus Recruits PDL1-Positive Cells at the Microenvironment in Pediatric Hodgkin Lymphoma.” Cancer Immunology, Immunotherapy 70(6): 1519–26. https://doi.org/10.1007/s00262-020-02787-2.

Kimura, Hiroshi, and Shigeyoshi Fujiwara. 2019. “Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases.” Frontiers in Pediatrics 6(JAN). https://www.frontiersin.org/article/10.3389/fped.2018.00417/full.

Medhat, A. R., & Aljanaby, A. A. J. (2022). Epidemiology of typhoid fever in Balad City, Iraq. International Journal of Health Sciences, 6(S1), 1049-1063. https://doi.org/10.53730/ijhs.v6nS1.4834

Murthy, Stacey L. et al. 2017. “Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma.” Baylor University Medical Center Proceedings 30(4): 443–44.

Nagpal, Poonam, Dante B. Descalzi-Montoya, and Niraj Lodhi. 2021. “The Circuitry of the Tumor Microenvironment in Adult and Pediatric Hodgkin Lymphoma: Cellular Composition, Cytokine Profile, EBV, and Exosomes.” Cancer Reports 4(2): 1–9.

Ok, Chi Young, Thomas G. Papathomas, L. Jeffrey Medeiros, and Ken H. Young. 2013. “EBV-Positive Diffuse Large B-Cell Lymphoma of the Elderly.” Blood 122(3): 328–40.

Saito, Eiko, and Junko Matsuoka. 2020. “International Comparison of Hodgkin and Non-Hodgkin Lymphoma Incidence.” Japanese Journal of Clinical Oncology 50(1): 96–97. https://academic.oup.com/jjco/article/50/1/96/5685786.

Salano, Valerie E. et al. 2021. “Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma.” JCO Global Oncology (7): 1406–12.

Sausen, Daniel G. et al. 2021. “Stress-Induced Epstein-Barr Virus Reactivation.” Biomolecules 11(9): 1–30.

Shimoyama, Yoshie et al. 2008. “Age-Related Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders: Special References to Lymphomas Surrounding This Newly Recognized Clinicopathologic Disease.” Cancer Science 99(6): 1085–91.

Sun, Haifeng et al. 2022. “Global, Regional and National Burden of Non-Hodgkin Lymphoma from 1990 to 2017: Estimates from Global Burden of Disease Study in 2017.” Annals of Medicine 54(1): 633–45. https://doi.org/10.1080/07853890.2022.2039957.

Sung, Hyuna et al. 2021. “Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.” CA: A Cancer Journal for Clinicians 71(3): 209–49.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937

Swerdlow, Steven H. et al. 2016. “The 2016 Revision of the World Health Organization Classification of Lymphoid Neoplasms.” Blood 127(20): 2375–90. https://ashpublications.org/blood/article/127/20/2375/35286/The-2016-revision-of-the-World-Health-Organization.

Thandra, Krishna C et al. 2021. “Epidemiology of Non-Hodgkin’s Lymphoma.” Medical Sciences 9(1): 5. https://www.mdpi.com/2076-3271/9/1/5.

Wang, Hao Wei, Jayalakshmi P. Balakrishna, Stefania Pittaluga, and Elaine S. Jaffe. 2019. “Diagnosis of Hodgkin Lymphoma in the Modern Era.” British Journal of Haematology 184(1): 45–59.

Wong, Yide et al. 2022. “Estimating the Global Burden of Epstein–Barr Virus-Related Cancers.” Journal of Cancer Research and Clinical Oncology 148(1): 31–46. https://doi.org/10.1007/s00432-021-03824-y.